Cited by 197Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCerebrospinal fluid and hydrocephalus

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

Open access

van Harten, Argonde C., Visser, Pieter Jelle, Pijnenburg, Yolande A.L., Teunissen, Charlotte E., Blankenstein, Marinus A., Scheltens, Philip, van der Flier, Wiesje M.·2013·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2012.08.004

Open this paper in CoChat — free account

Abstract

Background: The need to recognize Alzheimer's disease (AD) as early as possible led us to evaluate the predictive value of amyloid β(1‐42) (Aβ42), total tau (tau), and phosphorylated tau (ptau) in cerebrospinal fluid (CSF) for clinical progression in patients with subjective complaints. Methods: We recruited nondemented patients with subjective complaints (i.e., criteria for mild cognitive impairment [MCI] not fulfilled) from our memory clinic. We assessed the predictive value of CSF Aβ42, tau, and ptau for clinical progression using Cox proportional hazards models adjusted for age, gender, and baseline findings on the Mini‐Mental State Examination (MMSE). Clinical progression was defined as progression to MCI or AD. Results: We included 127 patients with subjective complaints (age 60 ± 10 years, 61 [48%] females, MMSE 29 ± 1). At baseline, Aβ42 and tau were abnormal in 20 patients (both 16%), and ptau in 32 patients (25%). Thirteen patients (10%) progressed to MCI (n = 11) or AD (n = 2). Aβ42 was the strongest predictor of progression to MCI or AD with an adjusted hazard ratio (HR) of 16.0 (3.8–66.4). The adjusted HR associated with tau was 2.8 (0.9–9.2) and with ptau 2.6 (0.8–8.2). Combinations of biomarkers had a lower predictive value than Aβ42 alone. Conclusion: Low Aβ42 was the strongest predictor of clinical progression in patients with subjective complaints. These results are in line with the hypothesis that the cascade of pathologic events starts with deposition of Aβ42, whereas neuronal degeneration and hyperphosphorylation of tau are more downstream events, closer to clinical manifestation of AD.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2012.08.004

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Self-citation
Telephone Interview for Cognitive Status
Brandt, J., Spencer, M., & Folstein, M. F. (1988) · PsycTESTS Dataset · doi:10.1037/t28542-000 · Cited by 1,504
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Frequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059

Flagged first, then by citations

Show all 43 references

1 of the 43 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–197 of 197

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
Hong, Y. J., Park, K. W., Kang, D., & Lee, J. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.1.19 · Cited by 25
The shift to a proteinopenia paradigm in neurodegeneration
Ezzat, K., Sturchio, A., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00001-1 · Cited by 26
Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network
de Vries, B. M., Golla, S. S. V., Ebenau, J. L., Verfaillie, S. C. J., Timmers, T., Heeman, F., Cysouw, M. C. F., van Berckel, B. N. M., van der Flier, W. M., Yaqub, M. M., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05006-3 · Cited by 24
Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status
Li, S., the DELCODE Study Group, Daamen, M., Scheef, L., Gaertner, F. C., Buchert, R., Buchmann, M., Büerger, K., Catak, C., Dobisch, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200472 · Cited by 25
Finding the falsification threshold of the toxic proteinopathy hypothesis in neurodegeneration
Espay, A. J., Herrup, K., & Daly, T. P. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00008-0 · Cited by 27
Chronic disease profiles of subjective memory complaints: a latent class analysis of older people in a rural Malaysian community
Yap, K. H., Warren, N., Allotey, P. A., & Reidpath, D. D. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1550632 · Cited by 24
Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
Eckerström, C., Svensson, J., Kettunen, P., Jonsson, M. A. G., & Eckerström, M. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12031 · Cited by 22
Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
Hu, H., Tan, L., Bi, Y., Xu, W., Tan, L., Shen, X., Hou, X., Ma, Y., Dong, Q., & Yu, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51153 · Cited by 20
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)
Reisberg, ‌., Torossian, C. L., Shulman, M. B., Monteiro, I. M., Boksay, I., Golomb, J. B., Guillo‐Benarous, F., Ulysse, A., Oo, T., Vedvyas, A., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180341 · Cited by 21
Cognitive Impairments in Alzheimer's Disease and Other Neurodegenerative Diseases
Sohrabi, H. R., & Weinborn, M. (2019) · doi:10.1002/9781119356752.ch9 · Cited by 20
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
de Leeuw, D. M., Trieu, C., Vromen, E. M., Blujdea, E. R., Verberk, I. M. W., Duits, F. H., Teunissen, C. E., Pijnenburg, Y. A. L., van der Flier, W. M., van Harten, A. C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.19919 · Cited by 23
Self-citation
Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration – A combined MRI & FDG-PET study
Woost, T. B., Dukart, J., Frisch, S., Barthel, H., Sabri, O., Mueller, K., & Schroeter, M. L. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.05.008 · Cited by 18
Computer‐assisted prediction of clinical progression in the earliest stages of AD
Rhodius‐Meester, H. F. M., Liedes, H., Koikkalainen, J. R., Wolfsgruber, S., Coll‐Padrós, N., Kornhuber, J., Peters, O., Jessen, F., Kleineidam, L., Molinuevo, J. L., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.09.001 · Cited by 19
Self-citation
Lifestyle Factors and Subjective Cognitive Impairment in Patients Seeking Help at a Memory Disorder Clinic: The Role of Negative Life Events
Andersson, C., Marklund, K., Walles, H., Hagman, G., & Miley-Åkerstedt, A. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000505573 · Cited by 19
Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative.
Rabin, L. A., Initiative, T. A. D. N., Sikkes, S. A. M., Tommet, D., Jones, R. N., Crane, P. K., Elbulok-Charcape, M. M., Dubbelman, M. A., Koscik, R. L., Amariglio, R. E., et al. (2023) · Neuropsychology · doi:10.1037/neu0000888 · Cited by 23
Biomarkers of Alzheimer’s Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review
Scarth, M., Rissanen, I. L., Scholten, R. J. P. M., & Geerlings, M. I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210218 · Cited by 18
Issues about the use of subjective cognitive decline in Alzheimer's disease research
Canevelli, M., Blasimme, A., Vanacore, N., Bruno, G., & Cesari, M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.07.154 · Cited by 17
For a Cognitive Model of Subjective Memory Awareness
Barba, G. D., Corte, V. L., & Dubois, B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150141 · Cited by 16
Associations between white matter hyperintensities and cognitive decline over three years in non-dementia older adults with memory complaints
Moon, S. Y., Barreto, P. D. S., Marie Chupin, A., Mangin, J., Bouyahia, A., Fillon, L., Andrieu, S., & Vellas, B. J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.06.031 · Cited by 16
Impact of a Multidomain Intensive Lifestyle Intervention on Complaints About Memory, Problem-Solving, and Decision-Making Abilities: The Action for Health in Diabetes Randomized Controlled Clinical Trial
Espeland, M. A., Dutton, G. R., Neiberg, R. H., Carmichael, O. T., Hayden, K. M., Johnson, K., Jeffery, R. W., Baker, L. D., Cook, D. R., Kitzman, D. W., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly124 · Cited by 16
Perceived environmental pollution and subjective cognitive decline (SCD) or SCD-related functional difficulties among the general population
Ju, Y. J., Lee, J. E., & Lee, S. Y. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12831-y · Cited by 15
Machine Learning Classification of Patients with Amnestic Mild Cognitive Impairment and Non-Amnestic Mild Cognitive Impairment from Written Picture Description Tasks
Kim, H. H., Hillis, A. E., & Themistocleous, C. K. (2024) · Brain Sciences · doi:10.3390/brainsci14070652 · Cited by 15
Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer’s disease
Ryu, S. Y., Lee, S. B., Kim, T. W., & Lee, T. J. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0604-7 · Cited by 15
Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder
Kerr, D. S., Stella, F., Radanovic, M., Aprahamian, I., Bertolucci, P. H. F., & Forlenza, O. V. (2016) · Bipolar Disorders · doi:10.1111/bdi.12367 · Cited by 15
BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project
van den Bosch, K. A., Verberk, I. M. W., Ebenau, J. L., van der Lee, S. J., Jansen, I. E., Prins, N. D., Scheltens, P., Teunissen, C. E., & van der Flier, W. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.018 · Cited by 13
Self-citation
Biomarcadores en la enfermedad de Alzheimer
Ribas, G. G., López-Sendón, J. L., & Caldentey, J. G. (2014) · Revista de Neurología · doi:10.33588/rn.5807.2013394 · Cited by 14
Different Cortical Thinning Patterns Depending on Their Prognosis in Individuals with Subjective Cognitive Decline
Lim, E. Y., Shim, Y. S., Hong, Y. J., Ryu, S. Y., Cho, A.-H., & Yang, D. W. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.4.113 · Cited by 14
The “when” matters: Evidence from memory markers in the clinical continuum of Alzheimer’s disease.
Forno, G., Parra, M. A., Thumala, D., Villagra, R., Cerda, M., Pedro Zitko, M., Ibáñez, A. M., Lillo, P., & Slachevsky, A. (2023) · Neuropsychology · doi:10.1037/neu0000891 · Cited by 13
Cognitive impairment without dementia: A current view of the problem
Starchina, Y. A. (2017) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2017-2-71-76 · Cited by 13
The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study
Hong, Y. J., Park, J. W., Lee, S. B., Kim, S., Kim, Y., Ryu, D.-W., Park, K. W., & Yang, D. W. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000519766 · Cited by 13
Cognitive Complaints in Memory Clinic Patients and in Depressive Patients: An Interpretative Phenomenological Analysis
Miebach, L., Wolfsgruber, S., Frommann, I., Fließbach, K., Jessen, F., Buckley, R. F., & Wagner, M. (2017) · The Gerontologist · doi:10.1093/geront/gnx208 · Cited by 12
Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline
Espenes, R., Kirsebom, B., Eriksson, C. M., Waterloo, K. K., Hessen, E., Johnsen, S. H., Selnes, P., & Fladby, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190712 · Cited by 13
Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
Kirsebom, B., Espenes, R., Waterloo, K. K., Hessen, E., Johnsen, S. H., Bråthen, G., Aarsland, D., & Fladby, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170385 · Cited by 12
Defining Amyloid Pathology in Persons With and Without Dementia Syndromes
Rosenberg, R. N. (2015) · JAMA · doi:10.1001/jama.2015.5361 · Cited by 11
Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline
Hsieh, C.-H., Ko, C.-A., Liang, C., Yeh, P.-K., Tsai, C., Tsai, C., Lin, G., Lin, Y., Tsai, M., & Yang, F. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1389595 · Cited by 11
Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task
Vergani, A. A., Mazzeo, S., Moschini, V., Burali, R., Lassi, M., Amato, L. G., Carpaneto, J., Salvestrini, G., Fabbiani, C., Giacomucci, G., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103760 · Cited by 11
Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease
Lemercier, P., Vergallo, A., Lista, S., Zetterberg, H., Blennow, K., Potier, M., Habert, M., Lejeune, F., Dubois, B., Teipel, S. J., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.005 · Cited by 10
Efficacy and neural mechanism of acupuncture treatment in older adults with subjective cognitive decline: study protocol for a randomised controlled clinical trial
Yan, C.-Q., Zhou, P., Wang, X., Tu, J. F., Hu, S., Huo, J., Wang, Z., Shi, G., Zhang, Y., Li, J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028317 · Cited by 10
A randomized control trial of a behavioral intervention for older adults with subjective cognitive complaints that combines cognitive rehabilitation strategies and lifestyle modifications
Denny, K. G., Chan, M. L., Gravano, J. T., Harvey, D. J., Meyer, O. L., Huss, O., & Farias, S. T. (2021) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2021.1965530 · Cited by 10
Mild cognitive impairment—amyloid and beyond
Scheltens, P. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.147 · Cited by 10
Self-citation
Difference in Amyloid Load Between Single Memory Domain and Multidomain Subjective Cognitive Decline: A Study from the SILCODE
Wang, X., Bi, Q., Lu, J., Chan, P., Hu, X., Su, L., Jessen, F., Lin, H., Han, C., Shu, N., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215373 · Cited by 8
Reduced Gray Matter Volume in Subjective Cognitive Decline: A Voxel-Based Morphometric Study
Choi, Y., Yoon, B.-N., Choi, S. H., Lim, M. K., Kim, H.-J., & Yang, D. W. (2015) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2015.14.4.143 · Cited by 7
Grey zone amyloid burden affects memory function: the SCIENCe project
Ebenau, J. L., Verfaillie, S. C. J., van den Bosch, K. A., Timmers, T., Wesselman, L. M. P., van Leeuwenstijn, M. S. S. A., Tuncel, H., Golla, S. S. V., Yaqub, M. M., Windhorst, A. D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05012-5 · Cited by 9
Self-citation
Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia
Bernardes, C., Lima, M., Duro, D., Silva‐Spínola, A., Durães, J., Tábuas‐Pereira, M., Baldeiras, I., Freitas, S., & Santana, I. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230916 · Cited by 8
Clusters of cognitive performance predict long‐term cognitive impairment in elderly patients with subjective memory complaints and healthy controls
Jiménez‐Huete, A., Villino‐Rodríguez, R. A., Ríos‐Rivera, M. M., Rognoni, T., Montoya‐Murillo, G., Arrondo, C., Zapata, C., Rodríguez-Oroz, M. C., Riverol, M., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13903 · Cited by 6
Incremental diagnostic value of 18F-Fluetemetamol PET in differential diagnoses of Alzheimer’s Disease-related neurodegenerative diseases from an unselected memory clinic cohort
Bao, Y., Shea, Y. F., Chiu, P. K., Kwan, J. S. K., Chan, F. H.-W., & Mak, H. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-14532-z · Cited by 7
Neuropsychiatric symptoms and metamemory across the life span: psychometric properties of the German Multifactorial Memory Questionnaire (MMQ)
Rekers, S., Heine, J., Thöne-Otto, A. I. T., & Finke, C. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12402-4 · Cited by 7
Alzheimer’s Disease-related Biomarkers in Aging Adults with Down Syndrome: Systematic Review
Bram, J. M. D. F., Talib, L. L., Joaquim, H. P. G., Carvalho, C. L., Gattaz, W. F., & Forlenza, O. V. (2019) · Current Psychiatry Research and Reviews · doi:10.2174/1573400515666190122152855 · Cited by 7
Effects of Subjective Memory Complaints (SMCs) and Social Capital on Self-Rated Health (SRH) in a Semirural Malaysian Population
Yap, K. H., Mohan, D., Stephan, B. C. M., Warren, N., Allotey, P. A., & Reidpath, D. D. (2019) · Journal of Aging Research · doi:10.1155/2019/9151802 · Cited by 7
AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State
Ibarra, R., Radanovic, M., Pais, M. V., Talib, L. L., & Forlenza, O. V. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720944237 · Cited by 8
Investigations of Memory Monitoring in Individuals With Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
Yu, H., Wang, K., Zhong, P., Cheng, H., Lv, X., & Yuan, L.-L. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000242 · Cited by 7
New tetracyclic systems integrated thienopyridine scaffold as an anti-dementia lead: in silico study and biological screening
Mahmoud, Z., Mohamed, L. W., Mohamed, K. O., Sayed, H. S., Fattah, M. A. A. E., & El-Malah, A. A. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-022-03013-7 · Cited by 6
Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review
Jacob, C., Tollenaere, M., Kachar, H., Potier, M., Deyn, P. P. D., & Dam, D. V. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41445 · Cited by 6
Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE
Wei, M., Yu, X., Hu, S., Hu, W., Shi, R., Wang, M., Zhong, J., Zhang, Q., Zhang, Y., Li, C., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241309105 · Cited by 5
The challenging concept of preclinical Alzheimer's disease
Wallon, D., & Garnier‐Crussard, A. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.07.016 · Cited by 6
Lower CSF A? is Associated with HAND in HIV-Infected Adults with a Family History of Dementia
Fazeli, P. L., Moore, D. J., Franklin, D. R., Umlauf, A., Heaton, R. K., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., Sacktor, N. C., et al. (2016) · Current HIV Research · doi:10.2174/1570162x14666151221145926 · Cited by 4
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Emergence of the Solution to an Important Unmet Need.
Teunissen, C. E., & Willemse, E. (2013) · PubMed · Cited by 3
Self-citation
Integrated bioinformatics and machine learning identify S100A9 and VGLL1 as hub genes for schizophrenia
Lv, J., Wang, X., & Qin, W. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1621219 · Cited by 2
The study of plaques and tangles makes few and inaccurate predictions about the main features of cognitive disorders: A narrative review
Abbate, C., & Gallucci, A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374319 · Cited by 2
Diagnostic Impact of Cerebrospinal Fluid Biomarkers in Atypical Dementias in Canada
van den Brink, S. E. M., Amrani, L. E., Therriault, J., Gauthier, S. G., Rosa‐Neto, P., & Vitali, P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.196 · Cited by 2
Pathology vs pathogenesis: Rationale and pitfalls in the clinicopathology model of neurodegeneration
Donadio, V. A., Sturchio, A., Rizzo, G., Abu‐Rumeileh, S., Liguori, R., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00001-8 · Cited by 2
The theoretical problems of “prodrome” and “phenoconversion” in neurodegeneration
Sturchio, A., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00002-x · Cited by 2
Subjective Cognitive Decline and Genetic Propensity for Dementia beyond Apolipoprotein ε4: A Systematic Review
Sampatakakis, S. N., Roma, M., & Scarmeas, N. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030129 · Cited by 2
Lumbalpunktion in der Demenzabklärung: Die Liquorpunktion ist unentbehrlich. Pro
Schulz, J. B. (2014) · Der Nervenarzt · doi:10.1007/s00115-013-3973-7 · Cited by 2
Alzheimer’s Disease and Other Neurodegenerative Disorders
Rosén, C., Zetterberg, H., & Blennow, K. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_20 · Cited by 2
One step towards dementia prevention
Frisoni, G. B., & Jessen, F. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30086-3 · Cited by 2
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
Mattsson, N., Grigoriou, S., & Zetterberg, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_11 · Cited by 2
Functional MRI Studies of Memory in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Zhu, J. K., Risacher, S. L., Wishart, H. A., & Saykin, A. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_30 · Cited by 2
Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes
Espay, A. J., Ezzat, K., & Sturchio, A. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13324 · Cited by 2
Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
Liguori, C., Izzi, F., Mercuri, N. B., & Placidi, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00262 · Cited by 2
Basal forebrain atrophy along the Alzheimer’s disease spectrum and its relevance for subjective cognitive declinePreprint
Li, S., Grothe, M. J., Daamen, M., Wolfsgruber, S., Brosseron, F., Büerger, K., Catak, C., Dobisch, L., Incesoy, E. I., Fließbach, K., et al. (2020) · doi:10.21203/rs.3.rs-20438/v1 · Cited by 3
Neuropsychiatric symptoms and metamemory across the lifespan—Psychometric properties of the German Multifactorial Memory Questionnaire (MMQ)Preprint
Rekers, S., Heine, J., Thöne-Otto, A. I. T., & Finke, C. (2024) · doi:10.31234/osf.io/8hmxu · Cited by 2
Proteomics As A Valid Tool In Biomarker Discovery For Alzheimer's DiseasePreprint
Magnelli, V. (2024) · Preprints.org · doi:10.20944/preprints202401.1595.v1 · Cited by 1
Dysphagia and Oral Health in Older Adults with Motoric Cognitive Risk Syndrome
İnal, Ö., Demirdel, S., Yıldırım, N. Ü., & Naharcı, M. İ. (2025) · Dysphagia · doi:10.1007/s00455-025-10849-9 · Cited by 2
Early Diagnosis and Risk of Conversion from Presymptomatic Stages
Menéndez‐González, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-07989-9_1 · Cited by 1
"I don't recognize myself", personality characteristics in subjective cognitive impairment and mild cognitive impairment
Ausén, B. (2013) · Figshare · Cited by 1
Neuroepidemiology: New Methods, Results, and Challenges in the Definition of the Early Phases of Alzheimer's Disease: Insights From Subjective Memory Complaints and Subjective Cognitive Decline
Logroscino, G., & Battista, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00008-6 · Cited by 1
The Effects of a Multiple-Modality Mind-Motor Program on Vascular Outcomes in Community-Dwelling Older Adults with Subjective Cognitive Complaints
Deosaran, A. M. (2015) · Scholarship@Western (Western University)
Alzheimer-Demenz: Praxis und neue Entwicklungen
Heneka, M. T. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-014-0002-8
Fluid biomarkers in Alzheimer's disease - current
Rosén, C., Hansson, O., Blennow, K., & Zetterberg, H. (2013)
Usefulness of18F-Florbetaben in Alzheimer's Disease Diagnosis
Lee, H.-Y., Im, I.-C., Song, M.-J., & Shin, S.-G. (2016) · Journal of the Korean Society of Radiology · doi:10.7742/jksr.2016.10.5.307
The Path of Alzheimer’s disease
Jansen, W. J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161125wj
Effect of liver x receptor target genes Apolipoprotein E and ATP-binding cassette transporter A1 on beta-amyloid dependent pathology in Alzheimer's disease model mice
Carter, A. B. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Diagnostiek van de ziekte van Alzheimer
van der Flier, W. M. (2018) · Neuropraxis · doi:10.1007/s12474-018-00205-z
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
Mattsson, N., & Zetterberg, H. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_9
Estudo prospectivo dos perfis neuropsicológicos e de neuroimagem molecular e estrutural em coortes de idosos cognitivamente normais, com declínio cognitivo subjetivo e com desempenho excepcional de memória (SuperAgers)
Studart‐Neto, A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-19072022-144906
A functional perspective on the conditional covariance comparison problem in dementia analysisPreprint
Guan, C., Gangopadhyay, A. K., & Initiative, T. A. D. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.19.572366
A Machine Learning Classification of Individuals with Mild Cognitive Impairment into Variants from WritingPreprint
Kim, H. H., Argye, H., & Themistocleous, C. K. (2024) · medRxiv · doi:10.1101/2024.02.16.24302965
Cerebral Amyloidosis in Individuals with Subjective Cognitive Decline: From Genetic Predisposition to Actual Cerebrospinal Fluid Measurements
Sampatakakis, S. N., Mourtzi, N., Charisis, S., Kalligerou, F., Mamalaki, E., Ntanasi, E., Hatzimanolis, A., Koutsis, G., Ramı́rez, A., Lambert, J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12051053
Additional file 1 of Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study
Sannemann, L., Schild, A.-K., Altenstein, S., Bartels, C., Brosseron, F., Büerger, K., Cosma, N. C., Fließbach, K., Freiesleben, S. D., Glanz, W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13106433
Associations between subjective cognitive concern, brain network connectivity, and cognitive performance in cognitively normal older adults
Albert, K., Boyd, B., McDonald, B. C., Dumas, J., Saykin, A. J., Taylor, W., & Newhouse, P. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100155
Vers une meilleure compréhension des facteurs psychoaffectifs (anxiété et dépression) dans le vieillissement normal et pathologique : liens avec la cognition et la neuroimagerie multimodale
Moulinet, I. (2020) · theses.fr (ABES) · doi:10.70675/45bad93dz6eeez45d1z8d85z5e83196b607c
Importance de la dimension émotionnelle dans l'évaluation cognitive de la maladie d'Alzheimer à la phase prodromale : prise en compte des stéréotypes liés au vieillissement et des états implicites d'anxiété et de dépression
Gauthier, K. (2021) · theses.fr (ABES) · doi:10.70675/e93bfacdzd348z45e6zac53zf9c5f7e715bf
Overview of subjective cognitive decline in Brazil: a narrative review
Soares, I. S., Studart‐Neto, A., & Brucki, S. M. D. (2026) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2025-0416
Cognitive dispersion in the Alzheimer’s disease spectrum
Marsault, J., Vallet, G. T., Joubert, S., & the CIMA-Q group (2026) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617726102082
Neuroplasticity and immune system are related to altered grey matter networks: a cohort study in sporadic Alzheimer’s disease
de Leeuw, D. M., Duits, F. H., Dicks, E., Vromen, E. M., Teunissen, C. E., Barkhof, F., van der Flier, W. M., Visser, P. J., & Tijms, B. M. (2026) · Brain Communications · doi:10.1093/braincomms/fcag257
Self-citation
The association of self- and interviewer-reported cognitive problems with frailty progression and subsequent all-cause mortality risk: a large-scale cohort study
Tan, M., Jiang, Z.-N., & Wan, X.-M. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09341-5

Authors: van Harten, A. C., Visser, P. J., Pijnenburg, Y. A. L., Teunissen, C. E., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M.
Affiliations: Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Maastricht University Medical Centre (NL)
Corresponding author: van Harten, Argonde C.
ORCID: van Harten, Argonde C.
Visser, Pieter Jelle
Pijnenburg, Yolande A.L.
Teunissen, Charlotte E.
Blankenstein, Marinus A.
Scheltens, Philip
van der Flier, Wiesje M.
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2012-12-10
Volume: 9
Issue: 5
Pages: 481-487
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2012.08.004
OpenAlex: W2013751858
Cited by: 197
References: 43
Citations by year: 2026: 4 · 2025: 9 · 2024: 11 · 2023: 11 · 2022: 5 · 2021: 11 · 2020: 19 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 16 · 2015: 20 · 2014: 19 · 2013: 9
FWCI: 10.97
Type: journal article
Language: en
Open access: green
research.vu.nl
Licence: other-oa
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Research Publications (Maastricht University) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Alzheimer Nederland and Stichting VUmc Fonds
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Keywords: Alzheimer's disease, amyloid-beta 42
MeSH terms: Alzheimer Disease, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Biomarkers, Proportional Hazards Models, Amyloid beta-Peptides, tau Proteins, Disease Progression, Early Diagnosis, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks